Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2016 2
2017 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Cancer Predisposition Syndromes in Neuro-oncology.
Na B, Shah S, Nghiemphu PL. Na B, et al. Semin Neurol. 2024 Feb;44(1):16-25. doi: 10.1055/s-0043-1777702. Epub 2023 Dec 14. Semin Neurol. 2024. PMID: 38096910 Review.
Autophagy and ethanol neurotoxicity.
Luo J. Luo J. Autophagy. 2014;10(12):2099-108. doi: 10.4161/15548627.2014.981916. Autophagy. 2014. PMID: 25484085 Free PMC article. Review.
Nervous system (NS) Tumors in Cancer Predisposition Syndromes.
Patil P, Pencheva BB, Patil VM, Fangusaro J. Patil P, et al. Neurotherapeutics. 2022 Oct;19(6):1752-1771. doi: 10.1007/s13311-022-01277-w. Epub 2022 Sep 2. Neurotherapeutics. 2022. PMID: 36056180 Free PMC article. Review.
Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.
Prizant H, Hammes SR. Prizant H, et al. Endocrinology. 2016 Sep;157(9):3374-83. doi: 10.1210/en.2016-1395. Epub 2016 Jul 13. Endocrinology. 2016. PMID: 27409646 Free PMC article. Review.
LAM cells contain inactivating mutations in genes encoding tuberous sclerosis 1 or 2, proteins that normally limit cell growth through suppression of mammalian target of rapamycin complex 1. ...
LAM cells contain inactivating mutations in genes encoding tuberous sclerosis 1 or 2, proteins that normally limit cell …
Taking aim at Alzheimer's disease through the mammalian target of rapamycin.
Maiese K. Maiese K. Ann Med. 2014 Dec;46(8):587-96. doi: 10.3109/07853890.2014.941921. Epub 2014 Aug 8. Ann Med. 2014. PMID: 25105207 Free PMC article. Review.
The mammalian target of rapamycin (mTOR) and its protein complexes mTOR Complex 1 (mTORC1) and mTOR Complex 2 (mTORC2) offer exciting and unique avenues of intervention for AD through the oversight of programmed cell death pathways of apoptosis, autophagy, and necroptosis. mTOR m …
The mammalian target of rapamycin (mTOR) and its protein complexes mTOR Complex 1 (mTORC1) and mTOR Complex 2 (mTORC2) offer exciting and un …
Molecular uropathology and cancer genetics for the urologist: key findings for classification and diagnosis.
Compérat E, Oszwald A, Wasinger G, Kläger J, Hassler MR, Shariat SF. Compérat E, et al. Curr Opin Urol. 2022 Sep 1;32(5):451-455. doi: 10.1097/MOU.0000000000001025. Epub 2022 Jul 18. Curr Opin Urol. 2022. PMID: 35916009 Review.
In the development of RCC, different genetic pathways such as Von Hippel-Lindau, but also tuberous sclerosis 1/2 and others play a major role in tumor development. ...
In the development of RCC, different genetic pathways such as Von Hippel-Lindau, but also tuberous sclerosis 1/2 and ot …
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature.
Starbuck KD, Drake RD, Budd GT, Rose PG. Starbuck KD, et al. Anticancer Res. 2016 Nov;36(11):6161-6164. doi: 10.21873/anticanres.11208. Anticancer Res. 2016. PMID: 27793946 Review.
Many have malignant behavior, and no successful treatment strategy has been established. Identification of mutations in the tuberous sclerosis 1 (TSC1) and TSC2 genes producing constitutive activation of the mammalian target of rapamycin (mTOR) pathway presen …
Many have malignant behavior, and no successful treatment strategy has been established. Identification of mutations in the tuberous